Sciatica is the loudest leading indicator on the board this week, topping the Emerging Demand Index at 1.71 on the back of a +23% week-over-week jump in Wikipedia pageviews. That's a consumer-attention signal, not a news-driven one — no major regulatory action or press event behind it — which typically converts into orthopedic and pain-management appointment demand within two to four weeks.

Emerging Demand — What to Watch

  • Sciatica (score 1.71) — Wikipedia pageviews +23% WoW, no FDA or trial catalyst. Pure consumer-driven attention. Route to Orthopedics and Pain Management capacity planning.
  • TMS Therapy (score 1.02) — Wikipedia pageviews +11% WoW. Sustained interest in non-pharmacologic depression treatment; a leading indicator for Mental Health intake queues.
  • Zepbound (score 0.78) — Wikipedia pageviews +7% WoW, tracking alongside Wegovy at +3%. GLP-1 consumer curiosity is steady rather than spiking — the category is normalizing into baseline demand.
  • Anxiety (score 0.69) — Wikipedia flat (+0%), but 39 new recruiting trials in the last 30 days — a pipeline signal that psychiatric sponsors are aggressively enrolling. Expect study-referral competition in major metros.
  • Depression (score 0.69) — Wikipedia +2% WoW with 27 new recruiting trials (30d). Same story as anxiety: attention is flat, but the research funnel is widening.

Search Intent

Google Trends returned no notable rising or falling national conditions this week, which is itself informative: the sciatica and TMS signals in EDI are running ahead of coincident search behavior. Operators who wait for Google Trends confirmation will be two to three weeks late to the sciatica wave already visible in Wikipedia traffic.

Structural Markets

Arkansas continues to over-index on nearly every chronic condition we track. Hypertension prevalence sits at 42.5% vs the 34% national baseline — a +8.5 point gap — and the state also runs hot on obesity (38.9% vs 34.3%), depression (25.2% vs 21.7%), and COPD (9.6% vs 6.3%). For multi-state operators, Arkansas is a case study in stacked comorbidity demand. Michigan and Ohio both post depression prevalence near 26.7% and 26.6% respectively, roughly 5 points above the national 21.7% — a structural tailwind for behavioral health expansion in the industrial Midwest.

Respiratory Watch

Texas is the only state showing a rising respiratory signal: COVID climbing in 16 of 24 reporting HSAs for the week ending 2026-06-27, even as RSV falls in all 27 HSAs and influenza falls in all 26. Michigan and New York RSV are broadly declining. This is a localized summer COVID uptick, not a national wave — but Texas urgent care and primary care operators should staff for a modest bump in the next two weeks.

The Bottom Line

Shift marketing spend toward sciatica and TMS keywords now — both are running ahead of Google Trends and represent buyable attention at pre-surge CPCs. Behavioral health operators should watch the trial pipeline: 66 new anxiety and depression trials in 30 days means research sites will start competing with clinics for the same patients. Texas operators, add a light COVID staffing buffer through mid-July.